Priya S. Kishnani

Priya Kishnani practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Priya Kishnani's NPI, 1114001021, was assigned on October 25, 2006. Priya Kishnani graduated from Topiwala National Medical College in 1990. Priya Kishnani holds North Carolina license 95-00972.

Priya Kishnani's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Priya Kishnani's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Priya Kishnani to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Priya Kishnani practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatrics is Priya Kishnani's primary specialty in the NPI Registry, under taxonomy code 208000000X. Priya Kishnani is board certified in clinical biochemical genetics by the American Board of Medical Genetics and Genomics. Priya Kishnani is licensed in North Carolina.

CMS data shows 15 Medicare services from Priya Kishnani across 1 procedure code in 2022, all of them office visits, for 15 Medicare patients. Medicare paid $1,513 for them. Every service was in an office.

CMS counts 15 Medicare patients who saw Priya Kishnani in 2024. The largest group is 85 and over, with 0 patients. 73% of them have high cholesterol. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Priya Kishnani's median patient age at 24, with 45% women.

In 2024, Priya Kishnani wrote 110 Medicare Part D claims for 11 patients. CMS names the drug for 103 of them, across 3 drugs with 11 or more claims each, at $8,572,469 in total drug cost. In 2023, CMS named 73 claims across 3 drugs.

Priya Kishnani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 422 papers to Priya Kishnani, published from 2002 to 2025. 2020 was the busiest year, with 30. The most frequent topics are Glycogen Storage Disease Type II, Enzyme Replacement Therapy and alpha-Glucosidases. Priya Kishnani has published most often in Mol Genet Metab. Priya Kishnani's most frequent co-authors are Stephanie A. Austin, MD, Dwight Dudley Koeberl and Kathryn M. Dahir, MD.

Dmand AI links Priya Kishnani to 15 clinical trials, 2 of them phase 1/2 studies. 7 are still active or recruiting. Conditions studied include Glycogen Storage Disease, Glycogen Storage Disease Type II and Down Syndrome. Duke University sponsors the most, 6. Open Payments lists research payments to Priya Kishnani that name 6 trials.

CMS Open Payments shows 641 general payments to Priya Kishnani from 22 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 51% of the total. Bayer Healthcare Pharmaceuticals Inc. paid the most, $2,780,494. It also lists 89 research payments totaling $120,813 from 2018 to 2024, naming 6 clinical trials.

Dmand AI lists 9 awards for Priya Kishnani, most recently Anna’s Angels Award in 2012.

Priya Kishnani graduated from Topiwala National Medical College in 1990.

Priya Kishnani is in network with 11 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.